Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit

BackgroundAdministration of intravenous idarucizumab to reverse dabigatran anticoagulation prior to thrombolysis for patients with acute ischemic stroke has been previously described, but not in th...